Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2568 0.1000%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: Xetra
  • Sector: Basic Materials
  • Industry: Chemicals
  • Sub-Industry: Chemicals-Diversified

Bayer AG

Add to Portfolio

BAYN:GY

50.900 EUR 0.450 0.89%

As of 11:35:11 ET on 05/25/2012.

Snapshot for Bayer AG (BAYN)

Open: 50.500 Day's Range: 50.140 - 51.240 Volume: 2,198,311 Bid: 50.890
Previous Close: 50.450 52wk Range: 35.360 - 58.640 1-Yr Rtn: -5.05% Ask: 50.930

Stock Chart for BAYN

No chart data available.
  • BAYN:GY 50.900
  • 1D
  • 1M
  • 1Y
50.450
Interactive BAYN Chart

Previous Close

Key Statistics for BAYN

Current P/E Ratio (ttm) 14.8397
Estimated P/E (12/2012) 9.8334
Earnings Per Share (EUR) (ttm) 3.4300
Est. EPS (EUR) (12/2012) 5.1610
Est. PEG Ratio 1.2289
Market Cap (M EUR) 42,091.64
Shares Outstanding (M) 826.95
Enterprise Value (M EUR) (ttm) 49,089.64
Enterprise Value/EBITDA (ttm) 5.58
Price/Book (mrq) 2.1040
Price/Sale (ttm) 1.1324
Dividend Indicated Gross Yield 3.2417
Next Earnings Announcement 07/27/2012
More BAYN Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for BAYN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)
More BAYN Income Statement Data
  • Total Assets
  • Total Liabilities (M/EUR)
  • Debt to Assets (%)
More BAYN Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/EUR)
More BAYN Cash Flow Data

Company Profile & Key Executives for BAYN

Bayer AG produces and markets healthcare and agricultural products, and polymers. The Company manufactures products that include aspirin, antibiotics, anti-infectives, and cardiovascular, oncology, and central nervous system drugs, over-the-counter medications, diagnostics, animal health products, crop protection products, plastics, and polyurethanes.

Marijn E DekkersChairman-Mgmt Board/CEOWerner BaumannCFO/Member-Mgmt Board
Wolfgang PlischkeCTO/Member-Mgmt BoardRichard PottChief Strategy & HR Ofcr
More Company Profile & Key Executives for BAYN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements